J. Robert Spiegel
Affiliations
- Director at Geron Corp (GERN), 2025-07-01
- Director at Renovorx Inc. (RNXT), 2024-10-02
- Director at Cyclacel Pharmaceuticals Inc. (CYCC), 2023-07-03
- Director at Athenex Inc. (ATNX), 2023-04-24
- Director at Old Ayala Inc (AYLA), 2023-01-24
- Director at Ayala Pharmaceuticals Inc. (ADXS), 2023-01-23
- Director at Edge Therapeutics Inc. (EDGE), 2019-03-18
- Director at Sucampo Pharmaceuticals Inc. (SCMP), 2018-02-13
- Chief Medical Officer at Ptc Therapeutics Inc. (PTCT), 2016-01-06
- Director at Talon Therapeutics Inc. (TLON), 2013-07-18
- Director at Capstone Therapeutics Corp. (CAPS), 2012-01-03
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| RNXT | $0.00 | 40,983 | $0.00 | 40,983 | 2024-01-26 | Filing |
| EDGE | $11.00 | 3,000 | $33,000.00 | 37,112 | 2015-10-06 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| GERN | $6.85 | 35,000 | $239,750.00 | 65,576 | 2018-09-13 | Filing |
| GERN | $6.85 | 35,000 | $239,750.00 | 65,576 | 2018-09-13 | Filing |
| GERN | $6.85 | 35,000 | $239,750.00 | 65,576 | 2018-09-13 | Filing |
| GERN | $6.85 | 15,000 | $102,750.00 | 65,576 | 2018-09-13 | Filing |
| GERN | $6.85 | 10,000 | $68,500.00 | 65,576 | 2018-09-13 | Filing |